Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)—basis and current status

A major shift in the approach to the management of pancreatic ductal adenocarcinomas (PDACs) has been the recognition of the systemic nature of the disease even in clinically and radiologically limited disease stages. The recalcitrant nature of PDAC is intrinsically related to the lack of therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramaswamy, Anant, Srinivas, Sujay, Chaudhari, Vikram, Bhargava, Prabhat, Bhandare, Manish, Shrikhande, Shailesh V, Ostwal, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085164/
https://www.ncbi.nlm.nih.gov/pubmed/35685956
http://dx.doi.org/10.3332/ecancer.2022.1367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085164/
https://www.ncbi.nlm.nih.gov/pubmed/35685956
http://dx.doi.org/10.3332/ecancer.2022.1367

Ejemplares similares